Clinical trial
Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages…
NCT00401557 · Yale University, Other · Completed
Key facts
| NCT number | NCT00401557 |
|---|---|
| Title | Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection |
| Official title | Intervenable Host - Leishmania (Viannia) Interactions - Project 3: Immune and Inflammatory Responses in L. (Viannia) Infection - Aim 3: Mechanisms Relating to the Distinct in Vitro Susceptibility of Human Macrophages to L. Viannia Infection |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leishmaniasis |
| Enrollment | 34 |
| Start date | Dec 1, 2006 |
| Completion | Apr 1, 2010 |
| First posted | Nov 20, 2006 |
| Last update posted | Mar 30, 2020 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: